: FDA approves treatment for people with mild forms of Alzheimer’s 0 06.01.2023 22:47 MarketWatch.com Leqembi, which was developed by Eisai and Biogen, will cost about $26,000 a year Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
